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ABSTRACT: Freeze-drying a biodegradable polymer, poly(L-lactic acid) (PLLA) from 
1,4-dioxane solutions provided very porous spherical particles of ca. 3 mm in radius 
with specific surface area of 8 − 13 m2 g−1. The surface of the particle was found to be 
less porous compared with its interior. To apply the freeze-dried PLLA (FDPLLA) to 
drug delivery system, its morphology and drug releasing kinetics were investigated, 
bovine serum albumin (BSA) being used as a model drug compound. Immersion of 
FDPLLA into a BSA aqueous solution gave BSA-loaded FDPLLA, where mass fraction 
of the adsorbed BSA reached up to 79%. Time-dependent release profile of BSA in 
water suggested a two-step mechanism: (1) very rapid release of BSA deposited on and 
near the particle surface, which results in an initial burst, and (2) leaching of BSA from 
the interior of the particle by the diffusion process. It was suggested that the latter 
process is largely governed by the surface porosity. The porosity of both the interior and 
surface was found to decrease remarkably as the concentration of the original PLLA / 
1,4-dioxane solution increases, C0. Thus, C0 is a key parameter that controls the loading 
and releasing of BSA. 
 
 
1. Introduction 
In recent decades, controlled drug release from capsules made from biodegradable and 
biocompatible polymers has been extensively studied. Polymer microspheres with 
dispersed medication are often used for this purpose [1]. In general, the drug release 
from microspheres are considered to occur both by degradation of the polymer matrix 
and by simple diffusion of the drug molecules. It has been revealed that various factors 
affect the feature of drug release, such as the size and structure of the microsphere, 
porosity, chemistry, degradability and molar mass of the polymer material, and pH value 
of the medium [1]. Furthermore, pH-sensitive release technique has been developed 
[2-4]. 
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Microspheres for the drug release have been prepared by polymerization method or by 
solvent removing method [1]. Vinyl polymer microcapsules can be prepared by 
emulsion, suspension, or dispersion polymerization [1,5]. Furthermore, controlled/living 
radical polymerization, which has been developed recently, can provide microspheres 
with well-controlled morphology [6]. On the other hand, for biodegradable polymers 
such as poly(L-lactic acid) (PLLA), poly(glycolic acid) (PGA), and various naturally 
occurring polymers, microspheres are usually prepared by solvent evaporation or spray 
drying method [7-17]. 
 
It needs to be noted that porous biodegradable polymer particles can also be prepared by 
freeze-drying technique [18], and by solution crystallization method [19]. We have 
prepared porous PLLA particles by the freeze-drying method from 1,4-dioxane 
solutions, and have investigated their structure and thermal properties precisely [18,20]. 
It has been demonstrated that the interior of the freeze-dried PLLA (FDPLLA) is very 
porous consisting of thin membranes forming a fine, randomly arrayed tissue. In 
addition, crystallizability of FDPLLA is remarkably high due to the mobile surface layer 
of the fine membranes, and thus, the range of crystallinity that can be achieved is 
expanded from that of the bulk PLLA. The FDPLLA seems to be suitable for a carrier in 
controlled drug delivery system because of its high void content and biocompatibility. 
The porosity of the FDPLLA is expected to be controlled by freeze-drying conditions. 
Additionally, it seems that the shape and size of the freeze-dried material can be 
controlled by the method of freezing. For example, if the solution is frozen as droplets, 
sphere-shaped material is yielded, and if it is frozen in a space between two flat 
substrates with a spacer, a plate-like one is yielded. 
 
In this paper, we investigate the possibility of applying the porous FDPLLA to 
controlled drug release system. We prepare protein-loaded FDPLLA particles with 
radius of ca. 3 mm, and examine their morphology. We here employ a protein, bovine 
serum albumin (BSA) as a model drug compound. BSA can be loaded into the FDPLLA 
particle by simply immersing them into a BSA aqueous solution and subsequent drying. 
The release kinetics of BSA from the BSA-loaded FDPLLA in water is investigated, 
and the results are discussed in conjunction with the morphology. 
 
2. Experimental Methods 
2.1. Preparation and characterization of FDPLLA 
PLLA with a molar mass of 210 kDa containing 98% L units was supplied from Mitsui 
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Chemicals Co. 1,4-Dioxane was purchased from Nacalai Tesque, which was distilled 
before use. PLLA/1,4-dioxane solutions of which the PLLA concentration of C0 = 2.0, 
5.0, and 8.0wt% were prepared. The solution was directly poured into liquid N2 (77 K) 
drop by drop so as to the solution was rapidly frozen. The frozen droplets were dried 
under vacuum for 168 h to remove the frozen solvent by sublimation, which yielded 
FDPLLA spherical particles with high porosity. The diameter of the particle was 
approximately 3 mm, being almost independent of C0. More detailed procedure of 
freeze-drying is described elsewhere [18,20]. Gravimetric measurement after heating at 
190°C revealed that the residual solvent contained in the FDPLLA was estimated to be 
less than 0.1wt%. We confirmed by differential scanning calorimetry (DSC) and 
wide-angle x-ray scattering (WAXS) that the as-prepared FDPLLA is completely 
amorphous as we reported elsewhere [20]. Additionally, we also prepared crystallized 
FDPLLA by annealing as-prepared FDPLLA at 115°C for 15 min. The crystallinity of 
the crystallized samples was evaluated from the net heat of endotherm detected during a 
heating scan of DSC at 10 K min−1. Specific surface area of the obtained FDPLLA, σ 
was evaluated by the Brunauer-Emmett-Teller (BET) adsorption isotherm of krypton. 
Volume fraction of void in the particle, rv was also evaluated by measuring the mass and 
apparent size of the particle. Literature value 1.248 g cm–3 for the density of amorphous 
PLLA was used in this evaluation [21]. Scanning electron microscopy (SEM) was 
performed to investigate the morphology of FDPLLA particles by using a Hitachi 
S-2600H electron microscope. 
 
2.2. Loading and releasing of BSA 
BSA (66,776 Da, lyophilized powder, >96%,) was purchased from Sigma-Aldrich. 
FDPLLA was immersed in an aqueous solution of BSA (20wt%) in the following 
procedure. FDPLLA particles were placed in a sandwich cell that was made of two glass 
plates and a rubber spacer, and were degassed under vacuum together with a BSA 
solution in a vacuum chamber (see Figure 1). Then, the open side of the cell was 
immersed in the BSA solution, followed by releasing the air into the chamber to 
atmospheric pressure. This method allows the solution to permeate thoroughly into the 
interior of the FDPLLA particle. On the contrary, when FDPLLA particle was simply 
added to the BSA solution, the solution hardly permeated into FDPLLA because of very 
high hydrophobicity of PLLA. After 10 min, the FDPLLA immersed in the solution was 
then separated and dried at room temperature in atmosphere for 24 h, followed by 
drying under vacuum for 24 h. The mass of BSA loaded in FDPLLA was evaluated by 
gravimetric measurement. 
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In the release experiments, the ratio of BSA-loaded FDPLLA / water was determined so 
as to the expected final absorbance of BSA at 279 nm is in the rage 0.5 − 0.6. In a 
typical experiment, 50 mg of BSA-loaded FDPLLA with C0 = 2.0wt% was immersed in 
40 mL of distilled water. The mixture was subject to constant stirring, the temperature 
being controlled at 37.0 ± 0.1°C. The amount of released BSA was measured by 
monitoring ultraviolet (UV) absorption at 279 nm, where a peak characteristic of BSA is 
located with a molar absorption coefficient of 43,824 M−1 cm−1. The UV measurements 
were done by using a UV spectrometer Hitachi U-3900H. From the results, 
time-dependent profile of the BSA concentration of the aqueous phase was evaluated. 
 
3. Results and Discussion 
3.1. Morphology 
The yielded FDPLLA particles were revealed to be very porous. Table 1 shows specific 
surface area σ and void fraction rv (volume fraction of void) of FDPLLA particles. The 
void content was evaluated from averaged values of apparent radius and mass of the 
particle. It is noted from Table 1 that for amorphous FDPLLA, C0 + rv approximately 
equals 100%. This means that the shape of the as-freeze-dried sphere is originated from 
the solution droplet: the frozen droplets undergo no shrinkage upon freeze-drying. 
Figure 2 shows scanning electron micrographs for FDPLLA particles. We see that the 
porosity is greater for lower C0. The thickness of the thin membranes that form fine 
tissue in the interior was estimated to be 100 – 200 nm from electron microscopy, which 
coincides with the results of specific surface area: thickness of a hypothetical flat film df 
that has the same specific surface area was estimated as df = 2 / (ρσ), where ρ is the 
density of amorphous PLLA, and it ranged from 120 to 191 nm (see Table 1). 
 
Figure 2 also shows that the surface of the sphere is less porous than that in the interior. 
Fine tissue that is typically seen in the interior appears to have melted on the surface, 
which results in reduction of surface porosity. This is typically observed in Figure 2 (c) 
and (e). It appears that a less porous skin is formed on the surface. By analyzing the 
SEM images, we estimated surface porosity as void fraction of the surface, Avoid /At, 
where Avoid is the area of the voids (pores) on the surface, and At is the total area of the 
surface. The results are presented in Table 2. The surface porosity decreases with 
increasing C0, and it is extremely low for C0 = 8.0wt%. The formation of the surface 
skin layer may have occurred during freezing. When a droplet of the solution is 
quenched in liquid N2, solid-liquid micro-phase separation would occur first, i.e., 
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crystallized solvent (solid phase) and unfrozen solution (liquid phase) may be formed. 
As the freezing process proceeds, the liquid phase becomes concentrated and finally it 
vitrifies when most of the solvent has moved to the frozen phase. Although the whole 
frozen process occurs within a few seconds in liquid N2, the intermediate liquid phase 
may have enough time to relax by reducing its interfacial area, which leads to surface 
melting. This process may occur preferentially on the surface where free space for the 
relaxation is available. 
 
The mass fraction of BSA loaded in the FDPLLA is presented in Table 3, which is 
defined as fBSA = mBSA / mt, where mBSA is the mass of BSA adsorbed in FDPLLA, and 
mt is the total mass of BSA-loaded FDPLLA. The obtained values of fBSA are extremely 
large compared with the PLLA scaffold prepared by the phase separation method [22]. 
This feature is originated from the high porosity of the present FDPLLA, which seems 
to be suitable for drug delivery applications. Figure 3 shows morphology of the 
BSA-loaded FDPLLAs. The interior of the particle exhibits a similar feature of porous 
morphology to that of the unloaded FDPLLA. The loaded BSA in the interior of the 
particle exists as agglomerates, which is typically seen in Figure 3 (b). The high 
porosity for the BSA-loaded FDPLLA is reasonably understood from their void fraction 
rv,loaded presented in Table 3: it is rather high even after the BSA adsorption, indicating 
that the BSA-loaded FDPLLA is still very porous. Here, rv,loaded was estimated from fBSA 
as 
      



 BSA
PLLA
BSA
BSA
vloadedv, 1
1)1(1 

f
frr   (1) 
where rv is the void fraction before the BSA loading, and ρPLLA and ρBSA (1.07 g cm–3) 
are the densities of PLLA and BSA, respectively. On the other hand, the surface of the 
particle seems to be covered with deposited BSA, and the voids on the surface is hidden 
for C0 = 5.0 and 8.0wt%. From electron micrographs, the deposited BSA layer on the 
surface for C0 = 5.0 and 8.0wt% was roughly estimated to be as thin as 0.5 – 1 μm, 
which does not alter the apparent size of the particle significantly. As for C0 = 2.0wt%, 
the surface is still ragged, which may be originated from the very porous surface shown 
in Figure 2 (a). 
 
We found that the apparent size of FDPLLA particles is reduced upon isothermal 
crystallization at 115°C for 15 min. This tendency was remarkable for C0 = 2.0wt%. 
Additionally, the spherical shape was deformed into indefinite shape. The apparent 
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averaged radius is presented in Table 1 in the parentheses. This is just a rough 
estimation, because the particles were not spherical. Table 1 also shows rv values 
estimated from this averaged radius. Figure 4 shows a typical morphology of the 
interior of crystallized FDPLLA (C0 = 8.0wt%). Aggregation of curved fine layers is 
observed; each layer is probably made of stacked crystalline lamellae of PLLA. The 
crystallinity of these samples was revealed to be in the range 0.14 – 0.16. The space 
(void) between them was found to be reduced upon crystallization, which is consistent 
with the reduction of the apparent size of the particle (see Table 1). As for the BSA 
loading, fBSA is smaller than that for the corresponding amorphous FDPLLA as shown in 
Table 3. It is most likely that this is due to the reduction of void fraction upon 
crystallization. 
 
3.2. Release kinetics 
As the crystallized FDPLLA particles have indefinite shape which seems to prevent 
simple kinetic analysis, we here report the release data only from the amorphous 
FDPLLA. The amount of BSA released into water from the FDPLLA was evaluated by 
UV absorbance at 279 nm. Figure 5 shows release of BSA with respect to elapsed time 
as presented by [BSA]t / [BSA]∞, where [BSA]t is the BSA concentration in water at 
time t, and [BSA]∞ is the final value of the BSA concentration that was estimated from 
the total mass of BSA loaded in the FDPLLA. It is clearly seen that the release rate 
increases as C0 decreases. For the three samples, a major portion of BSA release occurs 
within at least several hours, which suggests that the release occurs mainly by the 
diffusion mechanism prior to the degradation of PLLA: we confirmed that significant 
hydrolysis of PLLA in water under the present condition takes more than several days. 
 
We infer that the C0 dependence of release rate may be due to the difference in surface 
porosity. Additionally, it is seen that a burst of release occurs in the early period, which 
is probably due to rapid solvation of BSA deposited on the surface of the particles as 
observed in Figure 3 (a), (c), and (e). We speculate that the release of BSA from the 
interior of the particle occurs in two subsequent processes: permeation of water into the 
FDPLLA sphere, and the diffusion of BSA out of the particle. Both of these processes 
are affected significantly by the surface porosity. The values of Avoid /At in Table 2 
indicate that the surface porosity decreases remarkably with increasing C0. The interior 
porosity of the particle also decreases with increasing C0 as shown in Table 1, but this 
dependence is weaker than that of the surface porosity. Thus, it is likely that the release 
rate due to the diffusion process from the interior is largely governed by the surface 
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porosity. 
 
The profiles in Figure 5 suggest that the release takes place in two steps: dissolution of 
the BSA deposited on or near the surface occurs first, which is responsible for the initial 
burst, and then, BSA leaches out from the interior of the particle. The first step occurs 
within a few minutes, as evidenced by non-zero values of [BSA]t / [BSA]∞ at 60 s in 
Figure 5 (0.1 – 0.3). The release of the second step commences after certain induction 
period, which is needed for water to permeate into the interior of the particle, and this 
depends strongly on the surface porosity as discussed above. The release rate due to the 
second step is governed by the diffusion process of BSA in the particle and through the 
surface skin with less porosity. 
 
To analyze the time-evolution profiles in Figure 5, we assume a model of Fickian 
diffusion from a non-swellable sphere [23]. In this case, an analytical expression for 
[BSA]t / [BSA]∞ is given by 
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where D is the diffusion coefficient of BSA travelling in the FDPLLA particle, and a is 
the radius of the FDPLLA sphere. We further takes into account the initial burst as a 
baseline fraction parameter b, and the induction period for the second step as ti, thus, the 
time-dependent release is expressed by 
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The experimental profiles were fitted with eq (3) by non-linear least squares fitting, D 
and ti being treated as variable parameters, and the obtained best fit values are listed in 
Table 4. In the analysis, the series in eq (3) was cut off at n = 400; we confirmed that 
this does not affect the results significantly. Eq (3) assumes that both the distribution 
and diffusion rate of BSA is spatially uniform in the spherical particle, thus the 
evaluated D is regarded as an averaged diffusion coefficient over the interior of the 
sphere including the surface skin layer. 
 
The diffusion coefficient D for C0 = 2.0wt% is more than an order of magnitude greater 
than that for C0 = 8.0wt%. This can be understood by the large difference in the surface 
porosity between the two samples (Table 2). Thus, it is reasonable to consider that the 
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release rate due to the diffusion process is largely affected by the porosity of the surface 
skin layer. The baseline parameter b decreases with increasing C0, which implies that 
the release due to the initial burst is larger for lower C0. This suggests that the initial 
burst is originated not only from the BSA portion deposited on the surface but also from 
that deposited near the surface. The amount of the latter portion may be greater for 
higher surface porosity. The induction time ti increases with increasing C0. We infer that 
during the induction period, water goes into the particle, and this process is considered 
to be affected strongly by the surface porosity. 
 
4. Conclusions 
In this study, we have prepared BSA-loaded FDPLLA particles and have investigated 
their morphology and release kinetics of BSA into water. We have found that the 
porosity and specific surface area of the present FDPLLA are rather high, which leads to 
prominent ability of protein loading. The surface of FDPLLA particle is less porous than 
the interior, which is suggested to affect significantly the release rate of BSA. The 
concentration C0 of the original solution, from which FDPLLA is prepared, seems to be 
a key parameter that controls both BSA loading and release rate: as C0 decreases, the 
loading of BSA increases, while the release rate becomes greater. 
 
The present results suggest that FDPLLA is a promising material as a carrier for 
controlled drug release. On the other hand, it may not be suitable for tissue engineering 
applications, because the size of the pore is too small for cell seeding, growth, and 
tissue formation. The release rate observed in this study may be too fast for a practical 
use in controlled releasing system. This problem could be overcome by arranging the 
surface of the FDPLLA particle by either chemical or physical treatment. In addition, 
the size of the particle could be arranged so as to be suitable for various medical 
administrations (ingestion or injection) by development of spray method on freezing 
with controlled viscosity of the solution. We are currently exploring these techniques. 
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TABLE 1: Averaged radius a, specific surface area σ, and void content rv of FDPLLA 
particle. 
________________________________________________________________________________________________________ 
 C0 (wt%)  a (mm)    σ (m2 g–1) df (nm) a     rv (vol%) 
________________________________________________________________________________________________________ 
 2.0 amorphous 1.47 ± 0.03   13.4  120  98.1 
 2.0 crystallized (0.8)      87.5 
 5.0 amorphous 1.58 ± 0.07 11.9  135  94.4 
 5.0 crystallized (1.1)      85.0 
 8.0 amorphous 1.49 ± 0.11  8.4  191  92.3 
 8.0 crystallized (1.1)      80.2 
_______________________________________________________________________________________________________ 
a Hypothetical membrane thickness estimated as df = 2 / (ρσ). 
 
 
 
TABLE 2: Void fraction on the surface, Avoid /At of FDPLLA particle. 
_____________________________________________________ 
 C0 (wt%)  Avoid /At (%) 
_____________________________________________________ 
 2.0 amorphous 67.3 
 5.0 amorphous 10.7 
 8.0 amorphous  3.0 
_____________________________________________________ 
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TABLE 3: Mass fraction of BSA fBSA and void fraction rv,loaded of BSA-loaded 
FDPLLA. 
______________________________________________________________________ 
 C0 (wt%)  fBSA (wt%) rv,loaded (vol%) 
______________________________________________________________________ 
 2.0 amorphous 79.1  89.7 
 2.0 crystallized 53.0  71.1 
 5.0 amorphous 63.4  83.1 
 5.0 crystallized 43.8  71.4 
 8.0 amorphous 51.3  82.8 
 8.0 crystallized 34.5  68.0 
______________________________________________________________________ 
 
 
 
TABLE 4: Parameters obtained from the analysis of [BSA]t / [BSA]∞ vs. time. 
________________________________________________________________________________ 
 C0 (wt%) b  ti (s)  D (m2 s−1) 
________________________________________________________________________________ 
 2.0  0.32  2.0 × 102 2.1 × 10−10 
 5.0  0.15  7.5 × 102 6.0 × 10−11 
 8.0  0.13  6.7 × 103 1.7 × 10−11 
________________________________________________________________________________ 
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Figure Captions 
FIGURE 1. Immersion of FDPLLA particles in BSA aqueous solution by using a cell 
made of glass plates and a rubber spacer. 
 
FIGURE 2: Electron microscopic images of the surface and interior of as-prepared 
FDPLLA particles. (a) C0 = 2.0wt%, surface, (b) C0 = 2.0wt%, interior, (c) C0 = 5.0wt%, 
surface, (d) C0 = 5.0wt%, interior, (e) C0 = 8.0wt%, surface, and (f) C0 = 8.0wt%, 
interior. 
 
FIGURE 3: Electron microscopic images of the surface and interior of BSA-loaded 
FDPLLA particles. (a) C0 = 2.0wt%, surface, (b) C0 = 2.0wt%, interior, (c) C0 = 5.0wt%, 
surface, (d) C0 = 5.0wt%, interior, (e) C0 = 8.0wt%, surface, and (f) C0 = 8.0wt%, 
interior. 
 
FIGURE 4: Electron microscopic image of the interior of crystallized FDPLLA particle 
with C0 = 8.0wt%. 
 
FIGURE 5: BSA release [BSA]t / [BSA]∞ at 37°C plotted against elapsed time. The 
solid curves indicate the results of the non-linear least squares fitting analysis. 
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